Transient elastography (FibroScan) for the non-invasive assessment of liver fibrosis: Current status and perspectives;Nicht invasive beurteilung des leberfibrosestadiums mit der transienten elastografie (FibroScan): Aktueller stand und perspektiven

Zeitschrift fur Gastroenterologie

Volumn 45, Issue 5, 2007, Pages 387-394

  Friedrich Rust, Mireen ^a   Zeuzem, S ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Elastography; FibroScan; Liver; Liver fibrosis; Non invasive marker of fibrosis

Indexed keywords

ANTIVIRUS AGENT;

CHRONIC LIVER DISEASE; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE SEVERITY; ELASTOGRAPHY; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MEDICAL DECISION MAKING; PROGNOSIS; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT RESPONSE; ACOUSTIC MICROSCOPY; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL PRACTICE; CLINICAL TRIAL; ECHOGRAPHY; FORECASTING; GERMANY; IMAGE ENHANCEMENT; INSTRUMENTATION; LIVER; METHODOLOGY;

CLINICAL TRIALS; FORECASTING; GERMANY; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER CIRRHOSIS; MICROSCOPY, ACOUSTIC; PHYSICIAN'S PRACTICE PATTERNS; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 34447261198     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-963008     Document Type: Review

References (95)

1. Zeuzem S. Standard treatment of acute and chronic hepatitis C. Z Gastroenterol 2004; 42: 714-719
2. Fleig WE, Krummenerl P, Lesske J et al. Diagnosis, progression and therapy of hepatitis C virus infection as well as viral infection in children and adolescents - results of an evidenced based consensus conference of the German Society for Alimentary Metabolic Disorders and and in cooperation with the Hepatitis Competence Network. Z Gastroenterol 2004; 42: 703-704
3. Fleig WE, Krummener P, Lesske J. Criteria for the definition of acute and chronic hepatitis C. Z Gastroenterol 2004; 42: 707-713
4. National Institutes of Health Consensus Development Conference Statement. Management of hepatitis C 2002 (June 10-12, 2002). Hepatology 2002; 36: S3-S20
5. Bravo AA, Sheth SC, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500
6. Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: redults of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000; 32: 477-481
7. Castera L, Negre I, Samii K et al. Pain experienced during percutaneous liver biopsy. Hepatology 1999; 30: 1529-1530
8. Froehlich F, Lamy O, Fried M et al. Practice and complications of liver biopsy. Results of a nationwide survey in Switzerland. Dig Dis Sci 1993; 38: 1480-1484
9. Lindor KD, Bru C, Jorgensen RA et al. The role of ultrasonography and automatic-needle biopsy In outpatient percutaneous liver biopsy. Hepatology 1996; 23: 1079-1083
10. Perrault J, McGill DB, Ott BJ et al. Liver biopsy: complications in 1000 inpatients and outpatients. Gastroenterology 1978; 74: 103-106
11. Bedossa P, Dargere D, Paradise V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457
12. Bedossa P, Poynard T, Naveau S et al. Observer variation in assessment of liver biopsies of alcoholic patients. Alcohol Clin Exp Res 1988; 12: 173-178
13. Maharaj B, Maharaj RJ, Leury WP et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986; 1: 523-525
14. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618
15. Pilette C, Rousselet MC, Bedossa P et al. Histopathological evaluation of liver fibrosis: quantitative image analysis vs semi-quantitative scores. Comparison with serum markers. J Hepatol 1998; 28: 439-446
16. Westin J, Lagging LM, Wejstal R et al. Interobserver study of liver histopathology using the Ishak score in patients with chronic hepatitis C virus infection. Liver 1999; 19: 183-187
17. Baunsgaard P, Sanchez GC, Lundborg CJ. The variation of pathological changes in the liver evaluated by double biopsies. Acta Pathol Microbiol Scand [A] 1979; 87: 51-57
18. Soloway RD, Baggenstoss AH, Schoenfield LJ et al. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 1971; 16: 1082-1086
19. Poynard T, Munteanu M, Imbert-Bismut F et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004; 50: 1344-1355
20. Callewaert N, Van Vlierberghe H, Van hecke A et al. Noninvasive diagnosis of liver cirrhosis using DNA-sequencer-based total serum protein glycomics. Nat Med 2004; 10: 429-434
21. Forns X, Ampurdanes S, Llovet JM et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002; 36: 986-992
22. Guechot J, Laudat A, Loria A et al. Diagnostic accuracy of hyaluronan and type III procollagen aminoterminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluates by ROC curve analysis. Clin Chem 1996; 42: 558-563
23. Hui AY, Chan HL, Wong VW et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol 2005; 100: 616-623
24. Imbert-Bismut F, Ratziu V, Pieroni L et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075
25. Murawaki Y, Ikuta Y, Okamoto K et al. Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C. J Gastroenterol 2001; 36: 399-406
26. Patel K, Muir AJ, McHutchison JG. Validation of a simple predictive model for the identification of mild hepatic fibrosis in chronic hepatitis C patients. Hepatology 2003; 37: 1222-1223
27. Patel K, Lajoie A, Heaton S et al. Clinical use of hyaluronic acid as a predictor of fibrosis change in hepatitis C. J Gastroenterol Hepatol 2003; 18: 253-257
28. Pohl A, Behling C, Oliver D et al. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Castroenterol 2001; 96: 3142-3146
29. Rosenberg WM. Rating fibrosis progresseion in chronic liver disease. J Hepatol 2003; 38: 357-360
30. Wai CT, Greenson JK, Fontana RJ et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526
31. Ziol M, Handra-Luca A, Kettaneh A et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54
32. Castera L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-350
33. Bedossa P. Proteomics and pathology. Ann Pathol 2003; 1: S25-S26
34. Rosenberg WM, Voelker M, Thiel R et al. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004; 127: 1704-1713
35. Foucher J, Chanteloup F, Vergniol J et al. Diagnosis of cirrhosis by transient elastography (Fibroscan): a prospective study. Gut 2005; 55: 403-408
36. Aube C, Oberti F, Korali N et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999; 30: 471-478
37. Bernatik T, Strobel D, Hahn EG et al. Doppler measurements: a surroga te marker of liver fibrosis? Eur J Gastroenterol Hepatol 2002; 14: 383-387
38. Colli A, Fraquelli M, Andreoletti M et al. Severe liver fibrosis or cirrhosis: accuracy of US for detection - analysis of 300 cases. Radiology 2003; 227: 89-94
39. Dietrich CF, Lee JH, Gottschalk R et al. Hepatic and portal vein flow pattern in correlation with intrahepatic fat deposition and liver histology in patients with chronic hepatitis C. Am J Roentgenol 1998; 171: 437-443
40. Lim AKP, Taylor-Robinson SD, Patel N et al. Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C. Gut 2005; 54: 128-133
41. Lim AKP, Patel N, Eckersley R et al. Hepatic vein transit time of Sono-Vue: a comparative study with Levovist. Radiology 2006; 240: 130-135
42. Colletta C, Smirne C, Fabris C et al. Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology 2005; 42: 838-845
43. Corpechot C, El Naggar A, Poujol-Robert A et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006; 43: 1118-1124
44. De Ledinghen V, Trimoulet P, Mannant PR et al. Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: Long-term follow-up of 196 patients (4535 patient-years). J Hepatol 2007; 46: 19-25
45. De Ledinghen V, Douvin C, Kettaneh A et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV/hepatitis C virus-coin- fected patients. J Acquir Immune Defic Syndr 2006; 41: 175-179
46. Foucher J, Castera L, Bernard PH et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol 2006; 18: 411-412
47. Gomez-Dominguez E, Mendoza J, Rubio S et al. Transient elastography: a valid alternative to biopsy in patients with chronic liver disease. Aliment Pharmacol Ther 2006; 24: 513-518
48. Kawamoto M, Mizuguchi T, Katsuramaki T et al. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers. World J Gastroenterol 2006; 12: 4325-4330
49. Kazemi F, Kettaneh A, N'kontchou G et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol 2006; 45: 230-235
50. Laharie D, Zerbib F, Adhoute X et al. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate. Aliment Pharmacol Ther 2006; 23: 1621-1628
51. Maida I, Nunez M, Rios MJ et al. Severe liver disease associated with prolonged exposure to antiviral drugs. J Acquir Immune Defic Syndr 2006; 42: 177-182
52. Masaki N, Imamura M, Kikuchi Y et al. Usefulness of elastometry in evaluating the extents of liver fibrosis in hemophiliacs coinfected with hepatitis C virus and human immunodeficiency virus. Hepatol Res 2006; 35: 135-139
53. Saito H, Tada S, Nakamoto N et al. Efficacy of non-invasive elastometry on staging of hepatic fibrosis. Hepatol Res 2004; 29: 97-103
54. Sandrin L, Fourquet B, Hasquenoph JM et al. Transient elastography: a new non-invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-1713
55. Yeh WC, Li PC, Jeng YM et al. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol 2002; 28: 467-474
56. Carrion JA, Navasa M, Bosch J et al. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006; 12: 1791-1798
57. Erhardt A, Lorke J, Vogt C et al. Transient elastography for diagnosing liver cirrhosis. Dtsch Med Wochenschr 2006; 131: 2765-2769
58. Ganne-Carrie N, Ziol M, de L V et al. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006; 44: 1511-1517
59. Konate A, Boursier J, Reaud S et al. Liver stiffness measurement by transient elastography: predictive factors of accuracy, success and reproducibility. Hepatology 2006; 44 (Supp 1): 452A
60. Fraquelli M, Rigamonti C, Conte D et al. Reproducibility of transient elastography (TE) in assessing hepatic fibrosis. Hepatology 2006; 44 (Suppl 1): 444A
61. Boursier J, Guilluy M, Gorea G et al. Liver stiffness measurement by transient elastography (FibroScan): is training necessary? Hepatology 2006; 44(Suppl 1): 465A
62. Munteanu M, Ngo Y, De Torres M et al. Three-dimensional and metabolic variability of FibroScan (transient elastography) measures in healthy volunteers. DDW 2006; Abstract ID: 545
63. Coco B, Oliveri F, Colombatto B et al. Liver stiffness measured by transient elastography: the influence of biochemical activity. J Hepatol 2006; 44(Suppl 2): S196A
64. Coco B, Oliveri F, Colombatto P et al. Monitoring liver stiffness: a new tool to measure liver fibrosis during therapy. Hepatology 2005; 42 (Suppl 1): 435A
65. De Ledinghen V, Beaugrand M, Kelleher TB et al. Prediction of liver fibrosis in non-alcoholic steatohepatitis (NASH): risk factors and diagnostic potential of liver elasticity using FibroScan. J Hepatol 2006; 44 (Suppl 2): S39A
66. Takeda J, Yasuda T, Kimura M et al. Noninvasive diagnosis of nonalcoholic steatohepatitis using elastometry. Hepatology 2006; 44 (Suppl 1): 652A
67. Fukuzawa Y, Kizawa S, Ohashi T et al. Efficacy of non-invasive hepatic fibrosis quantificated-evaluation by liver elasticity measurement in nonalcoholoc steatohepatitis (NASH) - comparison of ultrasonic transient elastography and histopathological diagnosis. Hepatology 2006; 44 (Suppl 1): 649A
68. Fukuzawa Y, Ohashi T, Matsumoto E et al. Efficacy of non-invasive hepatic fibrosis quantification by liver elasticity measurement in nonalcoholoc steatohepatitis (NASH) - comparison of ultrasonic transient elastography and histopathological diagnosis. DDW 2006; Abstract ID:539
69. Kelleher TB, MacFarlane C, De Ledinghen V et al. Risk factors and hepatic elastography (Fibroscan) in the prediction of hepatic fibrosis in non alcoholic steatohepatitis. DDW 2006; Abstract ID: 546
70. Corpechot C, El Naggar A, Poupon R. Gender and Liver: is the liver stiffness weaker in weaker sex? Hepatology 2006; 44: 513-514
71. Roulot D, Costes JL, Le Clesiau H et al. Liver stiffness values in subjects without known risk factor for chronic liver diseases. Hepatology 2006; 44 (Suppl 1): 490A
72. Castera L, Le Bail B, Foucher J et al. Prospective analysis of discordance between FibroScan and FibroTest when used in combination as first-line assessment of liver fibrosis in chronic hepatitis C. Hepatology 2005; 42 (Suppl 1): 440A
73. De Ledinghen V, Le Bail B, Rebouissoux L et al. FibroScan® is a new non-invasive method for the diagnosis of liver fibrosis in children: a prospective comparison with FibroSure®, and liver biopsy. Hepatology 2005; 42 (Suppl 1): 472A
74. Castera L, Van Hecke A, Trimoulet P et al. Independent validation and comparison with FibroScan, FibroTest and liver biopsy of clinical glycomics for the non invasive assessment of liver fibrosis in chronic hepatitis C. Hepatology 2005; 42 (Suppl 1): 436A
75. Foucher J, Vergniol J, Castera L et al. Fibrosis evaluation in chronic liver diseases: comparison of FibroScan® with liver biopsy, FibroTest®, Forns score, APRI, hyaluronan, prothrombin time, and AST/ALT ratio. J Hepatol 2005; 42 (Suppl 2): 78A
76. Le Tallec V, Le Bigot J, Gorea G et al. Combination of blood scores, doppler ultrasonography, and transient elastography for the diagnosis of liver fibrosis. Hepatology 2006; 44 (Suppl 1): 453A
77. Farnan R, Heitor F, Nasser I et al. Optimization of the diagnosis of cirrhosis comparing clinical, biochemical and radiological features with liver stiffness by FibroScan. Hepatology 2006; 44 (Suppl 1): 276A
78. Parkes J, Guha IN, Roderick P et al. Performance of serum marker panels for liver fibrosis in chronic hepatitis C. J Hepatol 2006; 44: 462-474
79. Coco B, Oliveri F, Colombatto P et al. Monitoring liver elasticity: a new tool to measure liver fibrosis during therapy. J Hepatol 2005; 42 (Suppl 2): 258A
80. De Ledinghen V, Castera L, Foucher J et al. Evaluation of fibrosis regression using FibroScan in HCV responder patients. A prospective controlled study. J Hepatol 2006; 44 (Suppl 2): S210A
81. Grando-Lemaire V, De Ledinghen V, Bourcier V et al. Liver stiffness measurement (LMS) as a tool to measure liver fibrosis in treated patients with chronic hepatitis C (CHC). J Hepatol 2006; 44 (Suppl 2): S214A
82. De Ledinghen V, Castera L, Foucher J et al. Evaluation of fibrosis evolution using non-invasive methods according to sustained virological response in HCV patients. A pilot prospective controlled study. Hepatology 2006; 44 (Suppl 1): 337A
83. Serejo F, Marinho R, Costa A et al. Transient elastography (FibroScan®) in chronic hepatitis C. Will it modify the assessment and the follow-up of treated patients? Hepatology 2006; 44 (Suppl 1): 322A-323A
84. De Ledinghen V, Foucher J, Castera L et al. Evaluation of fibrosis regression using non-invasive methods in very long-term follow-up of HCV responder patients. Hepatology 2006; 44 (Suppl 1): 317A
85. Foucher J, Castera L, Bernard PH et al. Assessment of cirrhosis and its severity by FibroScan and biochemical markers in alcoholic patients. J Hepatol 2006; 44 (Suppl 2): S39A
86. Morente A, Romero M, Barreiw P et al. Clinical manifestation of end-stage liver disease (ESLD) in patients with chronic viral hepatitis and advanced liver fibrosis assessed by elastography. Hepatology 2005; 42 (Suppl 1): 338A-339A
87. Kim JK, Kim HS, Park YN et al. Transient elastography: a new and useful non-invasive method in determination of endoscopic surveillence for esophageal varices in hepatitis B related compensated cirrhosis. Hepatology 2006; 44 (Suppl 1): 447A-448A
88. Nahon P, Kettaneh A, Lemoine M et al. Liver stiffness measurement (LSM) by FibroScan in cirrhotic patients with small hepatocellular carcinoma (HCC): retrospective study comparing 50 cases with 197 compensated Child-Pugh A cirrhotic patients without HCC. Hepatology 2006; 44 (Suppl 1): 513A
89. Bureau C, Metivier S, Peron JM et al. Prospective assessment of liver stiffness for the non-invasive diagnosis of portal hypertension. Hepatology 2006; 44 (Suppl 1): 467A-468A
90. Foucher J. Castera L, Adhoute X et al. Assessment of the severity of cirrhosis according to different values of FibroScan: a prospective study. Hepatology 2006; 44 (Suppl 1): 450A
91. Lemoine M, Katsahian S, Nahon P et al. Liver stiffness measurement is correlated with hepatic venous pressure gradient in patients with uncomplicated alcoholic and/or HCV related-cirrhosis. Hepatology 2006; 44 (Suppl 1): 204A
92. Khohkar A, Farnan R, MacFarlane C et al. Liver stiffness and biomarkers: correlation with cirrhosis, portal hypertension and hepatic synthetic function. Hepatology 2005; 42 (Suppl 1): 433A
93. Friedrich-Rust M, Ong MF, Herrmann E et al. Realtime-Elastography for non-invasive assessment of liver firbrosis in chronic viral hepatitis. Am J Roentgenol 2007; 188: 758-764
94. Rouviere O, Yin M, Dresner MA et al. MR elastography of the liver: preliminary results. Radiology 2006; 240: 440-448
95. Lewin M, Poujol-Robert A, Boelle PY et al. Diffusion-weighted MR imaging for the diagnosis of liver fibrosis in patients with chronic hepatitis C. Hepatology 2006; 44 (Suppl 1): 280A-281A